Teladoc (TDOC) Up 49% Year To Date: Will The Rally Continue?
Zacks Investment Research | Mar 04, 2020 08:22PM ET
Teladoc Health, Inc. (NYSE:TDOC) is in investors’ good books owing to its fast growing telehealth services business.
Teladoc Health is the leading global virtual healthcare provider with strong competitive advantages that address the most pressing challenges and trends in the delivery of healthcare around the world. The company’s innovation and long-standing operational excellence provide it with significant first-mover advantages.
Year to date, the stock has gained 48.7%, against its industry ’s decline of 3%. Its revenues have been increasing over the years driven by growth in membership and patient visits.
Increase in patient visits also reflects the fast growing adoption of telehealth services. In 2019, the company generated positive cash flows from operations for the first time since its inception. Also, its net loss narrowed over the years.
The company is also expanding its roster of clients, which reflects its competitive and comprehensive virtual offerings.
Teladoc is the only telehealth provider that has international presence. The company expanded its international presence through the acquisition of Advance Medical in 2018, which was built on its acquisition of Best Doctors in 2017. In 2019, the company launched its telehealth offering in Canada.
Recent regulatory changes, which now allow telehealth benefits to be part of Medicare Advantage (MA) plans is a positive for Teladoc. This should open up new opportunities for the company. Effective 2020, telemedicine services are eligible for reimbursement under MA. This is believed to increase the company’s market share as nearly 20 million of individuals, currently insured under MA, moves to telehealth services.
Teladoc is on track to deliver an integrated virtual care experience across platforms supporting acute complex and chronic care needs and addressing the mental health and physical health challenges in 2020. In this vein, the company made an investment in Vida Health. Teladoc Health will be the exclusive virtual care partner of Vida Health, collaborating to deliver chronic care solutions with increasing digital and clinical integration.
Recently, the company announced that it will acquire InTough Health via which it will be able to provide healthcare solutions ranging from critical to chronic to everyday care. The deal will expand the total addressable market (TAM) for Teladoc and open up another avenue for growth.
The company’s strong guidance, which points to revenue, membership, visit and EBITDA growth, gives investors a sense of optimism about it.
Teladoc carries a Zacks Rank #3 (Hold). Some better-ranked players in the same space are AMN Healthcare Services Inc. (NYSE:AMN) , Medpace Holdings, Inc. (NASDAQ:MEDP) and HealthEquity, Inc. (NASDAQ:HQY) . Each of these stocks carries a Zacks Rank #2 (Buy).
AMN Healthcare, Medpace Holdings and HealthEquity surpassed their estimates in the last reported quarter by 14.86%, 13.33% and 113.64%, respectively.
Get The News You Want
You can see Original post
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.